Defense Dept. Funds Ketamine Study For PTSD Treatment In 600 Service Members Veterans
About 67% of Seelos Therapeutics' investor base is looking to short. The analysis of current outlook of investing in Seelos Therapeutics suggests that many traders are alarmed regarding Seelos Therapeutics' prospects. Seelos Therapeutics' investing sentiment shows overall attitude of investors towards Seelos Therapeutics.
Seelos Therapeutics otc stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Seelos daily returns and investor perception about the current price of Seelos Therapeutics as well as its diversification or hedging effects on your existing portfolios.
Seelos |
A Department of Defense Health Agency-funded adaptive platform trial for alternative treatments for PTSD will test SLS-002 on some 600 active-duty service members and veterans.
Read at benzinga.com
![]() |
Seelos Therapeutics Fundamental Analysis
We analyze Seelos Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Seelos Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Seelos Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Debt To Equity
Debt To Equity Comparative Analysis
Seelos Therapeutics is currently under evaluation in debt to equity category among its peers. Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Seelos Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Seelos Therapeutics otc stock to make a market-neutral strategy. Peer analysis of Seelos Therapeutics could also be used in its relative valuation, which is a method of valuing Seelos Therapeutics by comparing valuation metrics with similar companies.
Peers
Seelos Therapeutics Related Equities
TPST | Tempest Therapeutics | 1.16 | ||||
EWTX | Edgewise Therapeutics | 0.11 | ||||
CYBN | Cybin | 0.88 | ||||
ITOS | Iteos Therapeutics | 0.94 | ||||
ENTX | Entera Bio | 1.43 | ||||
OPT | Opthea | 2.39 | ||||
GHRS | GH Research | 2.40 | ||||
SLNO | Soleno Therapeutics | 2.43 | ||||
CAPR | Capricor Therapeutics | 3.67 | ||||
MOLN | Molecular Partners | 4.88 | ||||
MNMD | Mind Medicine | 5.90 | ||||
AKTX | Akari Therapeutics | 8.49 | ||||
ATAI | ATAI Life | 8.54 | ||||
PULM | Pulmatrix | 12.22 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in income. Note that the Seelos Therapeutics information on this page should be used as a complementary analysis to other Seelos Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Consideration for investing in Seelos OTC Stock
If you are still planning to invest in Seelos Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Seelos Therapeutics' history and understand the potential risks before investing.
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |